News | July 10, 2024
Shilpa Pharma Lifesciences’ Unit 2 Raichur has cleared the ANVISA-Brazil GMP inspection
The Unit has been issued GMP Certification from ANVISA-Brazil
The Unit has been issued GMP Certification from ANVISA-Brazil
Globally, colorectal cancer impacts 1.9 million people each year, standing as a leading cause of cancer mortality
The built-in AI-trained algorithms will empower users to proactively intervene when their glucose levels require attention and before a complication can even occur
Dr. Roopal Thakkar joined Abbott/AbbVie in 2003 as part of the Physician Development Program
The academy has secured partnerships with 15 esteemed hospitals
Dabur's consolidated revenue is expected to register mid to high single digit growth during Q1 FY25
Felzartamab demonstrated positive interim results from the Phase 2 IgA nephropathy (IgAN) study
Vabysmo PFS is the first and only syringe prefilled with an FDA-approved bispecific antibody to treat retinal conditions that can cause blindness
CureVac receives €400 million upfront and up to an additional €1.05 billion in development, regulatory and sales milestone payments as well as tiered royalties; all previous financial considerations from the prior collaboration agreement replaced
Yann d’Hervé takes over responsibility for the Health Care business at Evonik, effective July 1
Subscribe To Our Newsletter & Stay Updated
